Monday 19 November 2018 |
| 09:00-17:00 | | Registration |
| 10:30-12:00 | | Symposium 1: Curing DiabetesChair(s):Shareen Forbes (Edinburgh) & Ketan Dhatariya (Norwich)Non-hormonal therapiesLOMOND AUDITORIUM |
| 10:30 | S1.1 | Immunotherapy for type 1 diabetesColin Dayan (Cardiff, Wales) |
| 11:00 | S1.2 | State of the art in islet cell therapy: preclinical advances in graft revascularizationWillem Staels (Brussels, Belgium) |
| 11:30 | S1.3 | Very low calories and type 2 diabetesMike Lean (Glasgow, United Kingdom) |
| 10:30-12:00 | | Symposium 2: Big Data and Bone DiseaseChair(s):Paul Ardunel (Sheffield) & Jarod Sze Choong Wong (Glasgow)Big Data and BoneBOISDALE |
| 10:30 | S2.1 | Osteoporosis Mega GWASBrent Richards (Montreal, Canada) |
| 11:00 | S2.2 | Functional Genomics: New in vivo models of skeletal disease (Role of the IMPC)Duncan Bassett (London) |
| 11:30 | S2.3 | How rare bone disease will advance bone biology (Role of the Musculoskeletal GeCIP)Kassim Javaid (Oxford, UK) |
| 10:30-12:00 | | Clinical Management Workshop 1: Aggressive Pituitary TumoursChair(s):Helen Simpson (London) & Claire Higham (Manchester)Bringing out the big gunsALSH |
| 10:30 | CMW1.1 | How and when to use temozolamide in pituitary tumoursBen Whitelaw (King's College Hospital NHS Foundation Trust, London, UK) |
| 11:00 | CMW1.2 | When to intervene in recurring pituitary tumoursCaroline Hayhurst (Cardiff) |
| 11:30 | CMW1.3 | Proton beam therapy-the futureYen-Ch-ing Chang (London) |
| 10:30-12:00 | | Skills 1: Presentation skillsChair(s):Caroline Gorvin (Birmingham) & Ruth Casey (Cambridge)CARRON |
| 10:30 | SK1.1 | How to write an AbstractPaul Newey (University of Dundee, Dundee, United Kingdom) |
| 10:50 | SK1.2 | Perfect Prize PostersFrancesca Spiga (Bristol) |
| 11:05 | SK1.3 | How to give a 10 minute talkLaura Matthews (Leeds) |
| 11:25 | SK1.4 | How to write a paperMaralyn Druce (Barts Health NHS Trust, London, UK) |
| 11:45 | SK1.5 | How do I respond to peer reviewColin Farquharson (Edinburgh) |
| 12:15-13:00 | | Master Class 1: PCOSLOMOND AUDITORIUM |
| 12:15 | MC1.1 | Polycystic ovary syndrome; The role of androgen excess in disease pathogenesis and metabolic dysfunction |
| 12:35 | MC1.2 | PCOS: ManagementStephen Franks (London) |
| 12:15-13:00 | | Meet the Expert 1: What the endocrinologist needs to know about geneticsALSH |
| 12:15 | MTE1.0 | What the endocrinologist needs to know about geneticsMarta Korbonits (London, UK) |
| 12:15-13:00 | | Meet the Expert 2: Glucocorticoids in metabolic healthBOISDALE |
| 12:15 | MTE2.0 | Glucocorticoids in metabolic healthOnno Meijer (Leiden, The Netherlands) |
| 12:15-13:00 | | Skills 2: How do I pass the SCEChair(s):Amir Sam (London)CARRON |
| 12:15 | FSK1 | How do I pass the SCEGraham Leese (Dundee, UK) |
| 13:00-14:15 | | LUNCH, EXHIBITION & POSTERSHALL 1 & 2 |
| 14:15-14:45 | | Plenary 1: SfE International Medal LectureChair(s):Graham Williams (London)LOMOND AUDITORIUM |
| 14:15 | PL1 | Puberty: what are the neuroendocrine triggers for the biological end of childhood?Ursula Kaiser (Boston, USA) |
| 14:45-15:15 | | Plenary 2: SfE Starling Medal LectureChair(s):Barbara McGowan (London)LOMOND AUDITORIUM |
| 14:45 | PL2 | Hepatic fatty acid metabolism: the effect of metabolic and nutritional stateLeanne Hodson (Oxford) |
| 15:30-17:00 | | Symposium 3: Horizons in Adrenal MedicineChair(s):Mark Sherlock (Dublin, Ireland) & Earn Gan (Newcastle)State of the adrenal - 2018LOMOND AUDITORIUM |
| 15:30 | S3.1 | Novel strategies in glucocorticoid replacementEystein Husebye (University of Bergen, Bergen, Norway) |
| 16:00 | S3.2 | Steroid metabolomics in adrenal incidentalomaIrina Bancos (Mayo Clinic, Minnesota, USA) |
| 16:30 | S3.3 | What’s new in adrenal carcinomaGary Hammer (University of Michigan , Michigan, USA) |
| 15:30-17:00 | | Symposium 4: New treatments for bone disordersChair(s):S. Faisal Ahmed (Glasgow) & Chantal Chenu (London)Bone TherapiesBOISDALE |
| 15:30 | S4.1 | New treatment for common bone disease (Abaloparatide)Felicia Cosman (New York, USA) |
| 16:00 | S4.2 | New treatments for rare bone diseasePaul Arundel (Sheffield Children’s NHS Foundation Trust, Sheffield, UK) |
| 16:30 | S4.3 | Rare bone disorders: New Genes, biology and therapeutic targetsOuti Makitie (Helsinki, Finland) |
| 15:30-17:00 | | Symposium 5: Breast CancerChair(s):Evan Simpson (Edinburgh) & Chris McCabe (Birmingham)Oestrogens and BeyondCARRON |
| 15:30 | S5.1 | Epigenetic modelling of the chromatin landscape in breast cancerLuca Magnani (London) |
| 16:00 | S5.2 | Metabolic pathways regulating breast cancer in obesityKristy A. Brown (New York, USA) |
| 16:30 | S5.3 | Oncogenomic studies in hormone-associated cancersWilbert Zwart (Netherlands Cancer Insitute, Amsterdam, The Netherlands) |
| 15:30-17:00 | | Oral Communications 1: Translational HighlightsChair(s):Carla Moran (Cambridge) & Paul Newey (Dundee)ALSH |
| 15:30 | OC1.1 | Resilient reproductive, bone and adrenal function in Expedition Ice Maiden, the first all-female, unassisted Antarctic crossing.Robert Gifford (University of Edinburgh, Edinburgh, UK) |
| 15:45 | OC1.2 | Vitamin D Insufficiency and Elevated Vitamin D Metabolite Ratios (VMR) are Associated with Increased Risk of Injuries: Results from the British Army Lower Limb Injury Prevention (ALLIP) StudyJonathan Tang (Norwich) |
| 16:00 | OC1.3 | Novel insights into the genetic architecture of thyroid diseasePeter Taylor (Cardiff University, Cardiff, UK) |
| 16:15 | OC1.4 | Whole Genome Sequence analysis establishes correct diagnosis for a syndromic form of hyperuricaemiaMark Stevenson (Oxford) |
| 16:30 | OC1.5 | In vivo and ex vivo metabolomics in succinate dehydrogenase deficient tumorigenesis.Ruth Casey (Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom) |
| 16:45 | OC1.6 | Germline CYP2W1*6 and CYP2B6*6 polymorphisms as predicting markers of sensitivity to mitotane treatment in advanced adrenocortical carcinoma: a multicentric ENSAT study.Cristina Ronchi (University of Birmingham, Birmingham, United Kingdom) |
| 17:00-17:30 | | Tea & CoffeeHALL 1 & 2 |
| 17:30-18:00 | | Plenary 3: SfE Medal LectureChair(s):Karen Chapman (Edinburgh)LOMOND AUDITORIUM |
| 17:30 | PL3 | HPA activity: Don’t forget the dynamicsStafford Lightman (Bristol) |
| 18:00-18:30 | | Plenary 4: SfE Transatlantic Medal LectureChair(s):Simon Pearce (Newcastle)LOMOND AUDITORIUM |
| 18:00 | PL4 | Circadian Clock Genes and the Transcriptional Architecture of the Clock MechanismJoseph Takahashi (Dallas, USA) |
| 18:30-19:15 | | Debate: This house believes that the gut is the conductor of the endocrine orchestraChair(s):Jeremy Tomlinson (Oxford)Brain vs GutLOMOND AUDITORIUM |
| 18:30 | D1.1 | PRO: This house believes that the gut is the conductor of the endocrine orchestraCarel Le Roux (Dublin, Ireland) |
| 18:45 | D1.2 | CON: This house believes that the gut is the conductor of the endocrine orchestraGiles Yeo (University of Cambridge, Cambridge, UK) |
| 19:15-19:20 | | City Welcome from Bailey Elaine Ballantyne (Deputy Lord Provost)LOMOND AUDITORIUM |
| 19:30-21:00 | | Presidential Welcome ReceptionHALL 1 & 2 |
| 19:45-21:00 | | Early Careers Dinner & QuizALSH |
Tuesday 20 November 2018 |
| 07:30-19:00 | | Registration |
| 07:45-08:30 | | RESEARCH INCUBATORChair(s):Jeremy Turner (Norwich) & Caroline Gorvin (Birmingham)Hosted by the Bone & Calcium NetworkDOCHART |
| NW1.1 | Prospero - Clinical Trial of Management of PHPTBill Fraser (Norwich, UK) |
| NW1.2 | Network Member survey discussion |
| NW1.3 | Update on Network Activities |
| 07:45-08:30 | | RESEARCH INCUBATORChair(s):Giles Yeo (Cambridge), Waljit Dhillo (London), Marta Korbonits (London), Craig Beall (Exeter), Andrew Childs (London), Stephen Franks (London), Barbara McGowan (London) & Kevin Murphy (London)Hosted by the Neuroendocrinology Network, Reproductive Endocrinology & Biology Network and the Metabolic & Obesity NetworkCARRON |
| NW2.1 | Dynamic assessment of circadian biology by automated ambulatory microdialysisThomas Upton (University of Bristol, Bristol, UK) |
| NW2.2 | The uterine natural killer cell differentiation pathwayRupsha Fraser (Edinburgh) |
| NW2.3 | Update on Network Activities |
| 08:30-09:00 | | Plenary 5: CET Visiting Professor LectureChair(s):Stephen Ball (Manchester)SIAD; a modern approachLOMOND AUDITORIUM |
| 08:30 | P5 | SIAD; a modern approachChristopher Thompson (Dublin, Ireland) |
| 09:00-10:00 | | Early Careers Endocrinologists' Prize LecturesChair(s):Chris McCabe (Birmingham) & Wiebke Arlt (Birmingham)LOMOND AUDITORIUM |
| 09:00 | EC1.1 | Neurokinin 3 receptor antagonism – the magic bullet for hot flushes?Julia Prague (Royal Devon and Exeter Hospital and University of Exeter Medical School, Devon and Exeter, UK) |
| 09:30 | EC1.2 | The Importance of Local Sex Steroid Action in the Regulation of FertilityDouglas Gibson (Edinburgh) |
| 10:00-10:15 | | Tea & CoffeeHALL 1 & 2 |
| 10:15-11:45 | | Oral communications 2: Early Career 'Best of the Best'Chair(s):Chris McCabe (Birmingham) & Wiebke Arlt (Birmingham)ALSH |
| 10:15 | OC2.1 | 24-hour adrenal steroid rhythms are readily detected by ULTRADIAN automated ambulatory microdialysis in manThomas Upton (University of Bristol, Bristol, UK) |
| 10:30 | OC2.2 | Comparison of acute effects of corticosterone versus cortisol (hydrocortisone) infusion in adults with congenital adrenal hyperplasiaCatriona Kyle (Western General Hospital, Edinburgh, UK) |
| 10:45 | OC2.3 | Prospective serum thyroid function and cognitive decline in the very old: the Newcastle 85+ studyEarn Gan (Newcastle upon Tyne) |
| 11:00 | OC2.4 | Biochemical analysis of radioiodine uptake enhancement in endocrine cancerMohammed Alshahrani (Birmingham, United Kingdom) |
| 11:15 | OC2.5 | Using integrative lipid systems biology to understand the role of Liver X receptors (LXRs) in male reproduction.Sheba Jarvis (Imperial College London, London, UK) |
| 11:30 | OC2.6 | Overexpression ofSKAP2in familial AIP mutation negativesomatotrophinomasHussain Al-Jabir (London) |
| 10:15-11:45 | | Clinical Management Workshop 2: Endocrine emergenciesChair(s):Karin Bradley (Bristol) & Catherine Napier (Newcastle)Too hot to handle?LOMOND AUDITORIUM |
| 10:15 | CMW2.1 | Adrenal crisis: prevention and managementMark Sherlock (Royal College of Surgeons in Ireland, Dublin, Ireland) |
| 10:45 | CMW2.2 | Phaechromocytoma crisisRuth Casey (Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom) |
| 11:15 | CMW2.3 | Thyrotoxic crisesCarla Moran (Beacon Hospital and University College Dublin, Dublin, Ireland) |
| 10:15-11:45 | | Symposium 6: The most important nine months; impact of maternal healthChair(s):Rebecca Reynolds (Edinburgh) & Robert Lindsay (Glasgow)Long term consequences for the offspringBOISDALE |
| 10:15 | S6.1 | Impact of maternal cholestasis on health of the offspringCatherine Williamson (Imperial College London, London, UK) |
| 10:45 | S6.2 | Impact of maternal diabetes on child healthSusan Ozanne (Cambridge, UK) |
| 11:15 | S6.3 | Biological mechanisms and environmental factors involved in brain programming by stressful early-life experiencesAniko Korosi (Utrecht, The Netherlands) |
| 10:15-11:45 | | Nurse Session 1 - Pituitary adenomas - beyond surgeryChair(s):Miriam Asia (Birmingham) & Louise Breen (London)CARRON |
| 10:15 | NS1.1 | Pre-treatment management of pituitary adenomasPatsy Coskeran (London) |
| 10:40 | NS1.2 | The role of gamma knife in the management of pituitary adenomasJohn Newell-Price (University of Sheffield, Sheffield, UK) |
| 11:05 | NS1.3 | Post-treatment management of the pituitary patientAlison Milne (Aberdeen) |
| 11:30 | NS1.4 | Patient experience of gamma knifePhilip Rouse (Bath) |
| 12:00-12:45 | | Meet the Expert 3: Biochemistry masterclassChair(s):Tricia Tan (London)LOMOND AUDITORIUM |
| 12:00 | MTE3.1 | Insulin assayDavid Halsall (Cambridge) |
| 12:15 | MTE3.2 | When and how to measure PTHrP and 1,25-D and FGF23William Fraser (Norwich) |
| 12:30 | MTE3.3 | IGF1 AssaysGwen Wark (Guilford) |
| 12:00-12:45 | | Meet the Expert 4: Brown adipose tissueCARRON |
| 12:00 | MTE4 | Brown adipose tissueJan Nedergaard (Stockholm, Sweden) |
| 12:00-12:45 | | Meet the Expert 5: Non-surgical management of incurable thyroid cancerDOCHART |
| 12:00 | MTE5 | Non-surgical management of incurable thyroid cancerMaria Alevizaki (Athens, Greece) |
| 12:00-12:45 | | Meet the Expert 6: Gender dysphoriaBOISDALE |
| 12:00 | MTE6 | Gender dsyphoriaLeighton Seal (St George's Hospital, London, UK) |
| 12:45-14:00 | | LUNCH, EXHIBITION & POSTERSHALL 1 & 2 |
| 13:00-14:00 | | Industry sponsored satellite symposiaDOCHART |
| 13:00-14:00 | | Industry sponsored satellite symposiaALSH |
| 14:00-15:30 | | Clinical Management Workshop 3: How do I... Chair(s):Colin Perry (Glasgow) & Catriona Kyle (Edinburgh)LOMOND AUDITORIUM |
| 14:00 | CMW3.1 | How do I... Manage diarrhoea in patients with NETsMark Strachan (Edinburgh) |
| 14:15 | CMW3.2 | How do I...obesity related hypogonadismDaniel Cuthbertson (Liverpool) |
| 14:30 | CMW3.3 | How do I...manage adults with CAHWiebke Arlt (MRC Laboratory of Medical Sciences, London, UK) |
| 14:45 | CMW3.4 | How do I...short statureHelena Gleeson (endocrinologist at Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom) |
| 15:00 | CMW3.5 | How do I…access and manage osteoporosis in younger adultsJarod Wong (Glasgow, UK) |
| 15:15 | CMW3.6 | How do I...manage persistent acromegaly following primary treatmentRobert Murray (Leeds Teaching Hospitals NHS Trust, Leeds Teaching Hospitals NHS Trust, Leeds, UK) |
| 14:00-15:30 | | Oral communications 3 (Clinical): Obesity & DiabetesChair(s):Alison McNeilly (Dundee)ALSH |
| 14:00 | OC3.1 | Kisspeptin stimulates insulin secretion and modulates serum metabolites in humansChioma Izzi-Engbeaya (Imperial College London, London, UK) |
| 14:15 | OC3.2 | Glucose regulates pancreatic β cell Ca2+ dynamics and connectivity in vivo in the anterior chamber of the mouse eye.Victoria Salem (Imperial College London, London, UK) |
| 14:30 | OC3.3 | Staging of non-alcoholic fatty liver disease through LC-MS/MS analysis of the urinary steroid metabolomeAhmad Moolla (Oxford) |
| 14:45 | OC3.4 | Knockout of Glucocorticoid Receptor on AgRP/NPY/GABA (ANG) Neurons Identifies a potential role for this neuronal population in mediating Glucocorticoid–induced Insulin Resistance in Female MiceErika Harno (Manchester) |
| 15:00 | OC3.5 | Hypothalamic Arcuate Glucokinase and its Downstream Pathways are Critical in Glucose HomeostasisRisheka Ratnasabapathy (London) |
| 15:15 | OC3.6 | 5β-reductase (AKR1D1) is a potent regulator of hepatic insulin sensitivity, carbohydrate and lipid metabolism in vitroand in vivoNikolaos Nikolaou (Oxford, United Kingdom) |
| 14:00-15:30 | | Applied Physiology Workshop - GPCRs: hotspots and complexes Chair(s):Marian Ludgate (Cardiff) & Rajesh Thakker (Oxford)Old dogs with new tricksBOISDALE |
| 14:00 | APW1.1 | Calcium-sensing at 25 yearsCaroline Gorvin (University of Birmingham, Birmingham, UK) |
| 14:30 | APW1.2 | FSH and thermogenesisMone Zaidi (Mount Sinai Professor of Clinical Medicine, Director, Center for Translational Medicine and Pharmacology, Icahn Sinai School of Medicine at Mount Sinai, New York, USA) |
| 15:00 | APW1.3 | The nanodomain organization of GPCR signalling: lessons from TSH receptors and beyondDavide Calebiro (University of Birmingham, UK) |
| 14:00-15:30 | | Nurse Session 2 - Adrenal crisis & steroid education: raising the safety barChair(s):Karen Campbell (Glasgow) & Christine Gibson (Manchester)CARRON |
| 14:00 | NS2.1 | The epidemiology of adrenal crisisAnna Mitchell (Newcastle University, Newcastle, UK) |
| 14:30 | NS2.2 | National Education Programme for Patients with Chronic Adrenal InsufficiencyGesine Meyer (Frankfurt, Germany) |
| 15:00 | NS2.3 | Adrenal crisis- not always the obvious and saving livesAnne Marland (Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, UK) |
| 15:20 | NS2.4 | Adrenal crisis- not always the obvious - Case StudyLisa Shepherd (University of Birmingham, Birmingham, UK) |
| 15:30-16:00 | | Tea & CoffeeHALL 1 & 2 |
| 16:00-17:30 | | Oral communications 4: Clinical HighlightsChair(s):Lisa Shepherd (Birmingham) & Chris Thompson (Dublin, Ireland)LOMOND AUDITORIUM |
| 16:00 | OC4.1 | Targeted molecular analysis in adrenocortical carcinomas: a strategy towards improved personalized prognosticationCristina Ronchi (University of Birmingham, Birmingham, United Kingdom) |
| 16:15 | OC4.2 | Kisspeptin- a novel clinical test of hypothalamic function in men with hypogonadotrophic hypogonadismPei Chia Eng (Imperial College London, London, UK) |
| 16:30 | OC4.3 | A novel non-invasive Short Synacthen Test validated in healthy adult and paediatric populationsCharlotte Elder (Sheffield Children’s NHS Foundation Trust, Sheffield, UK) |
| 16:45 | OC4.4 | An intravenous insulin protocol designed for pregnancy reduces neonatal hypoglycaemia after betamethasone administration in women with gestational diabetes.Christopher Rowe (Newcastle, Australia) |
| 17:00 | OC4.5 | Hypothalamic-Pituitary Adrenal axis recovery rate of patients with Glucocorticoid-Induced Adrenal Insufficiency (GC-induced AI)Chona Feliciano (Birmingham) |
| 17:15 | OC4.6 | 11C-Methionine PET/MRI is superior to MRI for localisation of functioning prolactinomas and may facilitate targeted interventionWaiel Bashari (Cambridge) |
| 16:00-17:30 | | Clinical Management Workshop 4: Treating troublesome menopausal symptomsChair(s):Annice Mukherjee (Manchester) & Amir Sam (London)Management of MenopauseBOISDALE |
| 16:00 | CMW4.1 | HRT – efficacy and safety - who and for how longNick Panay (London, UK) |
| 16:30 | CMW4.2 | Non-Hormonal Therapies for Climacteric SymptomsKeith Spowart (Glasgow) |
| 17:00 | CMW4.3 | Neurokinin B antagonism – novel therapy for menopausal flushingWaljit Dhillo (London, UK) |
| 16:00-17:30 | | Symposium 7: The microbiome in endocrine diseaseChair(s):Jeremy Tomlinson (Oxford) & Aygul Dagbasi (London)Bugs and hormonesALSH |
| 16:00 | S7.1 | The role of the gut microbiome in obesityJohnathan Swann (London) |
| 16:30 | S7.2 | The gut microbiota in ageing and inflammationGemma Walton (Reading) |
| 17:00 | S7.3 | A role for the microbiome in autoimmune Graves' disease and orbitopathyMarian Ludgate (Cardiff) |
| 16:00-17:30 | | Early Careers Endocrinologists: Navigating the Academic PathwayChair(s):Rowan Hardy (Birmingham) & Kate Lines (Oxford)Routes through the mazeCARRON |
| 16:00 | EC2.1 | The Scientific Fellowship RouteDavid Hodson (University of Oxford, Oxford, UK) |
| 16:18 | EC2.2 | The Clinical Academic RouteVictoria Salem (Imperial College London, London, UK) |
| 16:36 | EC2.3 | The route with a career breakMyriam Chimen (Birmingham) |
| 16:54 | EC2.4 | The Lecturship RouteMatthew Simmonds (Lincoln) |
| 17:12 | EC2.5 | What the funders are looking forLindsay Keir (London) |
| 17:45-18:15 | | Plenary 6: CET LectureChair(s):Stephen Ball (Manchester)Sex, steroids and development – clinical research from the NHSLOMOND AUDITORIUM |
| 17:45 | P6 | Sex, steroids and development – clinical research from the NHSGerard Conway (London) |
| 18:15-19:00 | | Society for Endocrinology AGMLOMOND AUDITORIUM |
| 19:00-21:00 | | Conference Dinner Drinks reception from 19:00hrs, seated by 20:00hrsGlasgow Science Centre |
Wednesday 21 November 2018 |
| 07:30-17:30 | | Registration |
| 07:45-08:30 | | RESEARCH INCUBATORChair(s):Jeremy Tomlinson (Oxford) & Scott MacKenzie (Glasgow)Hosted by the Adrenal & Cardiovascular NetworkDOCHART |
| NW3.1 | Guidelines for peri-operative steroid treatment in patients with adrenal insufficiency: Optimising management and future directions |
| NW3.2 | Update on Network Activities |
| 07:45-08:30 | | RESEARCH INCUBATORChair(s):Rajesh Thakker (Oxford) & Paul Newey (Dundee)Hosted by the Endocrine Neoplasia Syndromes NetworkBOISDALE |
| NW4.1 | Clinical trial for pancreatic neuroendocrine tumoursBen Challis (Cambidge) & Paul Newey) |
| NW4.2 | Establishing a UK RET research collaborative networkTom Kurzawinski (University College London Hospitals NHS Foundation Trust, London, UK) |
| NW4.3 | Update on Network Activities |
| 07:45-08:30 | | RESEARCH INCUBATORChair(s):Petros Perros (Newcastle-Upon-Tyne) & Carla Moran (Cambridge)Hosted by the Thyroid NetworkCARRON |
| NW5.1 | Agranulocytosis studyBijay Vaidya (Exeter) |
| NW5.2 | Weight and thyrotoxicosis proposalAngelos Kyriacou (Salford) |
| NW5.3 | Potential UK collaborative thyroid disease in pregnancy trailPeter Taylor (Cardiff University, Cardiff, UK) |
| NW5.4 | Update on Network Activities |
| NW5.5 | New leads for Thyroid Network |
| 08:30-09:00 | | Plenary 7: British Thyroid Association Pitt-Rivers LectureChair(s):Krishna Chatterjee (Cambridge)LOMOND AUDITORIUM |
| P7 | How should we define optimal thyroid function?Robin Peeters (Rotterdam, The Netherlands) |
| 09:00-09:30 | | Plenary 8: SfE Dale Medal LectureChair(s):Graham Williams (London)Disorders of Thyroid Hormone Action: insights into diverse biological processesLOMOND AUDITORIUM |
| P8 | Disorders of Thyroid Hormone Action: insights into diverse biological processesKrishna Chatterjee (Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK) |
| 09:45-11:15 | | Symposium 8: Thyroid in PregnancyChair(s):Robin Peeters (Rotterdam, The Netherlands) & Bijay Vaidya (Exeter)Thyroid trials throughout life what they mean for you LOMOND AUDITORIUM |
| 09:45 | S8.1 | TABLET TRIAL – implications for targeted levothyroxine in pregnancyKristien Boelaert (University of Birmingham, Birmingham, UK) |
| 10:15 | S8.2 | CATS Obstetric and development – implications for thyroid screening in pregnancyPeter Taylor (Cardiff University, Cardiff, UK) |
| 10:45 | S8.3 | Iodine supplementation in pregnancy and effect on offspring neurodevelopmentSarah Bath (Surrey) |
| 09:45-11:15 | | Senior EndocrinologistsChair(s):Paul Belchetz (Leeds) CARRON |
| 09:45 | SE1.1 | Plasma Steroid Bioavailability: Hormone versus MetaboliteGeoffery Hammond (Vancouver, Canada) |
| 10:15 | SE1.2 | Oestrogens: the good, the bad, and the unexpectedEvan Simpson (Edinburgh) |
| 10:45 | SE1.3 | Why did the Queen die?Ashley Grossman (Green Templeton College, University of Oxford, London, UK) |
| 09:45-11:15 | | Applied Physiology Workshop - Metabolites as hormones Chair(s):Gareth Lavery (Birmingham) & Edward Chambers (London)New hormones everywhere ALSH |
| 09:45 | APW2.1 | Metabolic and microbial investigation of weight loss surgeryJia Li (London) |
| 10:15 | APW2.2 | Short chain fatty acid signalling in human health and diseaseEdward Chambers (London) |
| 10:45 | APW2.3 | Gut metabolites and human healthLouis Cohen (New York, USA) |
| 09:45-11:15 | | Symposium 9: Induction and preservation of gonadal functionChair(s):Marie Freel (Glasgow) & Julia Prague (London)Start it, save itBOISDALE |
| 09:45 | S9.1 | How do I differentiate hypog hypog from constitutional delayNicola Bridges (London) |
| 10:15 | S9.2 | Induction of spermatogenesisRichard Quinton (Imperial College London, London, UK) |
| 10:45 | S9.3 | Preservation of fertilityMelanie Davies (University College London, London, UK) |
| 11:15-11:45 | | Tea & CoffeeHALL 1 & 2 |
| 11:45-12:30 | | Meet the Expert 7 - Thyroid Masterclass Chair(s):Anna Mitchell (Newcastle Upon Tyne)LOMOND AUDITORIUM |
| 11:45 | MTE7.1 | Central Hypothyroidism - Diagnostic VignettesNadia Schoenmakers (Cambridge Neuroscience, Cambridge, United Kingdom) |
| 12:05 | MTE7.2 | Grey cases in ThyroidologyPetros Perros (Newcastle, United Kingdom) |
| 11:45-12:30 | | Meet the Expert 8 - Circulating tumour cells in NETsCirculating tumour cells in NETsBOISDALE |
| 11:45 | MTE8 | Circulating tumour cells in NETsTim Meyer (London) |
| 11:45-12:30 | | Meet the Expert 9 - Pituitary ion channel activity in health and diseasePituitary ion channel activity in health and diseaseCARRON |
| 11:45 | MTE9 | Pituitary ion channel activity in health and diseaseMike Shipston (Edinburgh) |
| 11:45-12:30 | | Meet the Expert 10: Service ImprovementsChair(s):John Newell-Price (Sheffield)ALSH |
| 11:45 | MTE10 | Getting it right first time (GIRFT) in EndocrinologyJohn Wass (Nuffield Health Oxford Hospital, Oxford, UK) |
| 12:00 | MTE10 | The Society for Endocrinology peer review schemeAntonia Brooke (Exeter) |
| 12:15 | MTE10 | Optimising patient outcomes and time management: the perfect MDTHelen Simpson (University College London Hospital, London, UK) |
| 12:30-13:45 | | LUNCH, EXHIBITION & POSTERSHALL 1 & 2 |
| 13:45-15:15 | | Oral Communications 5: AdrenalChair(s):Stafford Lightman (Bristol) & Sheba Jarvis (London)BOISDALE |
| 13:45 | OC5.1 | Timed urinary steroid profiling of patients with different degrees of cortisol excess: a proposal for a new test for the diagnosis of Cushing’s syndrome.Alessandro Prete (Queen Elizabeth Hospital, Birmingham, UK) |
| 14:00 | OC5.2 | Residual adrenal function in autoimmune Addison’s disease – effect of dual therapy with rituximab and depot tetracosactideCatherine Napier (Newcastle upon Tyne Hospitals, Newcastle, UK) |
| 14:15 | OC5.3 | 11βHSD1 mediates therapeutic glucocorticoid-induced muscle atrophy in chronic inflammatory disease.Justine Webster (Birmingham) |
| 14:30 | OC5.4 | Glucocorticoid receptor-mediated signalling inhibits mesenchymal cell proliferation via repression of the V1 isoform of versican during mouse lung developmentKelly Short (Melbourne, Australia) |
| 14:45 | OC5.5 | Androgen modulation of mouse uterus: a tissue-based bioassay for testing endogenous and synthetic androgen receptor modulators (SARMs)Ioannis Simitsidellis (Edinburgh) |
| 15:00 | OC5.6 | Therapeutic glucocorticoids prevent local and systemic bone loss in the TNF-tg model of chronic inflammatory diseaseChloe Fenton (Birmingham) |
| 13:45-15:15 | | Clinical Management Workshop 5: How do I... Chair(s):Nicola Zammitt (Edinburgh) & Kerri Devine (Newcastle)LOMOND AUDITORIUM |
| 13:45 | CMW5.1 | How do I...manage endocrinopathies in HIV patientsAlison Wren (London) |
| 14:00 | CMW5.2 | How do I...manage Paget’s diseaseStephen Gallacher (Glasgow) |
| 14:15 | CMW5.3 | How do I...manage thyroid eye diseasePetros Perros (Newcastle, United Kingdom) |
| 14:30 | CMW5.4 | How do I...decide what drugs to stop to investigate primary aldosteronismMarie Freel (Queen Elizabeth University Hospital, Glasgow, UK) |
| 14:45 | CMW5.5 | How do I... which non-diabetic patients could benefit from a GLP-1 analogueBarbara McGowan (Guys & St Thomas NHS Trust, London, UK) |
| 15:00 | CMW5.6 | How do I...investigate sweatingMark Strachan (Edinburgh) |
| 13:45-15:15 | | Symposium 10: Pancreatic NETs an updateChair(s):Ruth Casey (Cambridge) & Mark Stevenson (London)Challenges and opportunities in PNETsCARRON |
| 13:45 | S10.1 | Managing Pancreatic Neuroendocrine Tumours in MEN1John Newell-Price (University of Sheffield, Sheffield, UK) |
| 14:15 | S10.2 | Advances in EUS and endotherapy in PNETsStephen Pereira (London) |
| 14:45 | S10.3 | Genetic Landscape of pancreatic neuroendocrine tumoursChrissie Thirlwell (Exeter, UK) |
| 13:45-15:15 | | Oral Communications 6: Neuroendocrinology and ReproductionChair(s):Douglas Gibson (Edinburgh) & Christopher Thompson (Dublin)ALSH |
| 13:45 | OC6.1 | A controlled cross-sectional study of bone microarchitecture in transgender individualsJeffrey Zajac (Australia) |
| 14:00 | OC6.2 | Towards an understanding of the function of the mineralocorticoid receptor in zebrafish: the stress response, behaviour and osmoregulationJack Paveley (Sheffield) |
| 14:15 | OC6.4 | Kisspeptin receptor activity in human granulosa lutein cellsLisa Owens (St James Hospital, Dublin, Ireland) |
| 14:30 | OC6.5 | Is the metabolic phenotype altered in decidualised stromal cells from women with endometriosis?Frances Collins (Edinburgh) |
| 14:45 | OC6.6 | An epigenetic modifier reduces proliferation in pituitary cells and suppresses calcium-sensing receptor signalling.Kate Lines (Oxford, United Kingdom) |
| 15:00 | OC6.3 | Gamma Knife Radiosurgery for the primary management of AcromegalyJohn Newell-Price (University of Sheffield, Sheffield, UK) |
| 15:30-16:00 | | Plenary 9: SfE European Medal LectureChair(s):Eleanor Davies (Glasgow)Molecular mechanisms in primary aldosteronismLOMOND AUDITORIUM |
| P9 | Molecular mechanisms in primary aldosteronismMaria-Christina Zennaro (Université Paris Cité, Paris , France) |
| 16:00-16:30 | | Plenary 10: SfE Jubilee LectureChair(s):Karen Chapman (Edinburgh)Ups and Downs of Nuclear Receptor ActionLOMOND AUDITORIUM |
| 16:00 | P10 | Ups and Downs of Nuclear Receptor ActionMalcom Parker (London) |
| 16:30-17:00 | | Awards CeremonyLOMOND AUDITORIUM |
| 17:00-17:15 | | Closing RemarksLOMOND AUDITORIUM |